Replication-competent adenoviral vectors which selectively replicate in
cancer cells are provided. The replication-competent viral vectors
comprise an E2F responsive promoter and/or a telomerase promoter
operatively linked to an adenoviral coding region. The
replication-competent adenoviral vectors effectively replicate in a
variety of types of cancer cells and find broad utility in the treatment
of cancer.